nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP3A4—Temozolomide—brain cancer	0.249	0.417	CbGbCtD
Mebendazole—CYP3A4—Lomustine—brain cancer	0.212	0.354	CbGbCtD
Mebendazole—ABCB1—Etoposide—brain cancer	0.0856	0.143	CbGbCtD
Mebendazole—CYP3A4—Etoposide—brain cancer	0.0513	0.0857	CbGbCtD
Mebendazole—TUBA1A—pons—brain cancer	0.0452	0.167	CbGeAlD
Mebendazole—TUBA1A—pineal body—brain cancer	0.0322	0.12	CbGeAlD
Mebendazole—TUBA1A—ganglion—brain cancer	0.0231	0.0858	CbGeAlD
Mebendazole—TUBA1A—hindbrain—brain cancer	0.0175	0.065	CbGeAlD
Mebendazole—TUBA1A—brainstem—brain cancer	0.0101	0.0373	CbGeAlD
Mebendazole—TUBA1A—telencephalon—brain cancer	0.00893	0.0331	CbGeAlD
Mebendazole—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00882	0.067	CbGpPWpGaD
Mebendazole—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00803	0.0609	CbGpPWpGaD
Mebendazole—TUBA1A—gonad—brain cancer	0.00745	0.0276	CbGeAlD
Mebendazole—TUBA1A—Regulation of PLK1 Activity at G2/M Transition—PPP1R12A—brain cancer	0.00742	0.0563	CbGpPWpGaD
Mebendazole—TUBA1A—pituitary gland—brain cancer	0.00727	0.0269	CbGeAlD
Mebendazole—TUBA1A—medulla oblongata—brain cancer	0.00701	0.026	CbGeAlD
Mebendazole—TUBA1A—midbrain—brain cancer	0.00641	0.0238	CbGeAlD
Mebendazole—TUBA1A—spinal cord—brain cancer	0.00625	0.0232	CbGeAlD
Mebendazole—TUBB4B—telencephalon—brain cancer	0.00595	0.0221	CbGeAlD
Mebendazole—TUBA1A—endocrine gland—brain cancer	0.00563	0.0209	CbGeAlD
Mebendazole—TUBA1A—G2/M Transition—PPP1R12A—brain cancer	0.00557	0.0423	CbGpPWpGaD
Mebendazole—TUBA1A—head—brain cancer	0.00556	0.0206	CbGeAlD
Mebendazole—TUBA1A—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.00549	0.0417	CbGpPWpGaD
Mebendazole—TUBA1A—central nervous system—brain cancer	0.00507	0.0188	CbGeAlD
Mebendazole—TUBB4B—gonad—brain cancer	0.00497	0.0184	CbGeAlD
Mebendazole—TUBA1A—cerebellum—brain cancer	0.00496	0.0184	CbGeAlD
Mebendazole—TUBB4B—pituitary gland—brain cancer	0.00484	0.018	CbGeAlD
Mebendazole—TUBB4B—medulla oblongata—brain cancer	0.00467	0.0173	CbGeAlD
Mebendazole—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—PPP1R12A—brain cancer	0.00448	0.034	CbGpPWpGaD
Mebendazole—TUBB4B—midbrain—brain cancer	0.00427	0.0158	CbGeAlD
Mebendazole—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00424	0.0322	CbGpPWpGaD
Mebendazole—TUBB4B—spinal cord—brain cancer	0.00417	0.0154	CbGeAlD
Mebendazole—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00408	0.0309	CbGpPWpGaD
Mebendazole—TUBA1A—brain—brain cancer	0.00403	0.0149	CbGeAlD
Mebendazole—TUBB4B—endocrine gland—brain cancer	0.00375	0.0139	CbGeAlD
Mebendazole—TUBB4B—head—brain cancer	0.0037	0.0137	CbGeAlD
Mebendazole—TUBB4B—Orphan transporters—S100A10—brain cancer	0.0036	0.0273	CbGpPWpGaD
Mebendazole—ABCB1—blood vessel—brain cancer	0.00357	0.0132	CbGeAlD
Mebendazole—TUBB4B—central nervous system—brain cancer	0.00338	0.0125	CbGeAlD
Mebendazole—TUBB4B—G2/M Transition—PPP1R12A—brain cancer	0.00336	0.0255	CbGpPWpGaD
Mebendazole—TUBB4B—Mitotic G2-G2/M phases—PPP1R12A—brain cancer	0.00332	0.0252	CbGpPWpGaD
Mebendazole—TUBB4B—cerebellum—brain cancer	0.00331	0.0123	CbGeAlD
Mebendazole—TUBA1A—p73 transcription factor network—CDK6—brain cancer	0.003	0.0228	CbGpPWpGaD
Mebendazole—TUBB4B—brain—brain cancer	0.00268	0.00995	CbGeAlD
Mebendazole—TUBA1A—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.00249	0.0189	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—BRCA2—brain cancer	0.00234	0.0177	CbGpPWpGaD
Mebendazole—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00232	0.0176	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—SIRT1—brain cancer	0.00229	0.0174	CbGpPWpGaD
Mebendazole—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00221	0.0168	CbGpPWpGaD
Mebendazole—CYP1A1—endocrine gland—brain cancer	0.0021	0.00779	CbGeAlD
Mebendazole—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.00209	0.0158	CbGpPWpGaD
Mebendazole—CYP1A1—head—brain cancer	0.00207	0.00769	CbGeAlD
Mebendazole—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00204	0.0155	CbGpPWpGaD
Mebendazole—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.00201	0.0152	CbGpPWpGaD
Mebendazole—CYP1A1—central nervous system—brain cancer	0.00189	0.00702	CbGeAlD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.00177	0.0135	CbGpPWpGaD
Mebendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00176	0.0134	CbGpPWpGaD
Mebendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00174	0.0132	CbGpPWpGaD
Mebendazole—ABCB1—telencephalon—brain cancer	0.00173	0.00641	CbGeAlD
Mebendazole—TUBA1A—Cell Cycle—PPP1R12A—brain cancer	0.00159	0.012	CbGpPWpGaD
Mebendazole—CYP3A4—endocrine gland—brain cancer	0.00154	0.00571	CbGeAlD
Mebendazole—TUBB4B—Parkin-Ubiquitin Proteasomal System pathway—CCNE1—brain cancer	0.0015	0.0114	CbGpPWpGaD
Mebendazole—CYP1A1—brain—brain cancer	0.0015	0.00557	CbGeAlD
Mebendazole—TUBA1A—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.00148	0.0112	CbGpPWpGaD
Mebendazole—ABCB1—gonad—brain cancer	0.00144	0.00535	CbGeAlD
Mebendazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00143	0.0109	CbGpPWpGaD
Mebendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00143	0.0108	CbGpPWpGaD
Mebendazole—ABCB1—pituitary gland—brain cancer	0.00141	0.00522	CbGeAlD
Mebendazole—CYP3A4—central nervous system—brain cancer	0.00139	0.00515	CbGeAlD
Mebendazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00136	0.0104	CbGpPWpGaD
Mebendazole—ABCB1—medulla oblongata—brain cancer	0.00136	0.00504	CbGeAlD
Mebendazole—TUBA1A—p73 transcription factor network—RELA—brain cancer	0.00127	0.00967	CbGpPWpGaD
Mebendazole—ABCB1—midbrain—brain cancer	0.00124	0.00461	CbGeAlD
Mebendazole—ABCB1—spinal cord—brain cancer	0.00121	0.00449	CbGeAlD
Mebendazole—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.0011	0.00834	CbGpPWpGaD
Mebendazole—ABCB1—endocrine gland—brain cancer	0.00109	0.00405	CbGeAlD
Mebendazole—ABCB1—head—brain cancer	0.00108	0.00399	CbGeAlD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.00107	0.00812	CbGpPWpGaD
Mebendazole—ABCB1—central nervous system—brain cancer	0.000983	0.00365	CbGeAlD
Mebendazole—ABCB1—cerebellum—brain cancer	0.000961	0.00356	CbGeAlD
Mebendazole—TUBB4B—Cell Cycle—PPP1R12A—brain cancer	0.000957	0.00726	CbGpPWpGaD
Mebendazole—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000939	0.00713	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000906	0.00688	CbGpPWpGaD
Mebendazole—TUBA1A—p73 transcription factor network—MYC—brain cancer	0.000897	0.00681	CbGpPWpGaD
Mebendazole—TUBB4B—Pathogenic Escherichia coli infection—CTNNB1—brain cancer	0.000893	0.00678	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—S100A10—brain cancer	0.000878	0.00666	CbGpPWpGaD
Mebendazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000866	0.00657	CbGpPWpGaD
Mebendazole—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000855	0.00649	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000807	0.00613	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000805	0.00611	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000782	0.00593	CbGpPWpGaD
Mebendazole—ABCB1—brain—brain cancer	0.000781	0.00289	CbGeAlD
Mebendazole—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000758	0.00575	CbGpPWpGaD
Mebendazole—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000748	0.00567	CbGpPWpGaD
Mebendazole—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000736	0.00558	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—SKP2—brain cancer	0.00072	0.00546	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK6—brain cancer	0.000717	0.00544	CbGpPWpGaD
Mebendazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000702	0.00533	CbGpPWpGaD
Mebendazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000652	0.00495	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK6—brain cancer	0.000641	0.00487	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000565	0.00429	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCNE1—brain cancer	0.00054	0.0041	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—BRCA2—brain cancer	0.000499	0.00379	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—SKP2—brain cancer	0.000486	0.00369	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCNE1—brain cancer	0.000483	0.00367	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—PCNA—brain cancer	0.000479	0.00363	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000451	0.00342	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—SKP2—brain cancer	0.000435	0.0033	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK6—brain cancer	0.000433	0.00329	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—PCNA—brain cancer	0.000428	0.00325	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDK4—brain cancer	0.000414	0.00314	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000406	0.00308	CbGpPWpGaD
Mebendazole—TUBB4B—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000405	0.00308	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK6—brain cancer	0.000387	0.00294	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000386	0.00293	CbGpPWpGaD
Mebendazole—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000373	0.00283	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDK4—brain cancer	0.00037	0.00281	CbGpPWpGaD
Mebendazole—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000368	0.00279	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000345	0.00262	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000326	0.00248	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000322	0.00244	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000318	0.00241	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000316	0.0024	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000311	0.00236	CbGpPWpGaD
Mebendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000311	0.00236	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000305	0.00232	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—BRCA2—brain cancer	0.000301	0.00229	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCNE1—brain cancer	0.000292	0.00221	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000291	0.00221	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—PCNA—brain cancer	0.000289	0.00219	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CDKN2A—brain cancer	0.000283	0.00215	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—CCND1—brain cancer	0.000267	0.00203	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000267	0.00203	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—PCNA—brain cancer	0.000258	0.00196	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000257	0.00195	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDK4—brain cancer	0.00025	0.0019	CbGpPWpGaD
Mebendazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000241	0.00183	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—CCND1—brain cancer	0.000239	0.00181	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDK4—brain cancer	0.000223	0.0017	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle, Mitotic—MYC—brain cancer	0.000214	0.00163	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000213	0.00162	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000211	0.0016	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—IL2—brain cancer	0.000211	0.0016	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000207	0.00157	CbGpPWpGaD
Mebendazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000207	0.00157	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000205	0.00155	CbGpPWpGaD
Mebendazole—TUBA1A—Metabolism of proteins—CTNNB1—brain cancer	0.000197	0.0015	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—MYC—brain cancer	0.000192	0.00145	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CDKN2A—brain cancer	0.000191	0.00145	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00019	0.00145	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000181	0.00138	CbGpPWpGaD
Mebendazole—ABCB1—Allograft Rejection—VEGFA—brain cancer	0.000179	0.00136	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CDKN2A—brain cancer	0.000171	0.0013	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—CCND1—brain cancer	0.000161	0.00122	CbGpPWpGaD
Mebendazole—TUBA1A—Cell Cycle—TP53—brain cancer	0.000157	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000157	0.00119	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000148	0.00112	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—CCND1—brain cancer	0.000144	0.00109	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2C9—brain cancer	0.00013	0.000984	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle, Mitotic—MYC—brain cancer	0.000129	0.000982	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000123	0.000935	CbGpPWpGaD
Mebendazole—TUBB4B—Metabolism of proteins—CTNNB1—brain cancer	0.000119	0.000904	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—MYC—brain cancer	0.000116	0.000878	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000115	0.00087	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—BSG—brain cancer	0.00011	0.000837	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2C9—brain cancer	0.000104	0.000786	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000101	0.000769	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.0001	0.000761	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—brain cancer	9.5e-05	0.000721	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—IDH1—brain cancer	9.48e-05	0.000719	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.83e-05	0.00067	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—BSG—brain cancer	8.8e-05	0.000668	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.12e-05	0.000617	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.94e-05	0.000603	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.72e-05	0.000586	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—IDH1—brain cancer	7.57e-05	0.000575	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ENO2—brain cancer	7.49e-05	0.000569	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.67e-05	0.000506	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2C9—brain cancer	6.38e-05	0.000484	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ENO2—brain cancer	5.98e-05	0.000454	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—BSG—brain cancer	5.42e-05	0.000412	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—IDH1—brain cancer	4.66e-05	0.000354	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ENO2—brain cancer	3.69e-05	0.00028	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—brain cancer	3.44e-05	0.000261	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—brain cancer	2.75e-05	0.000208	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—brain cancer	1.69e-05	0.000128	CbGpPWpGaD
